• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

My Best Ideas for (the Start of) 2014

Let's run through them.
By GARY DVORCHAK
Jan 05, 2014 | 06:00 PM EST
Stocks quotes in this article: HP, MPC, PKG, DD, BA, XYL, PCLN, NUS, MJN, ENR, FRX, GILD, OZN, PRU, RHT, FB

Allow me to cheat, just slightly.

All the Real Money contributors are offering their best ideas for 2014, and I will do the same here. All of these ideas are buyable right now, I own most of them in my growth-at-a-reasonable-price (GARP) strategy, and I am actively research any names I do not own. You should research these stocks for your own portfolio.

However, like many portfolio managers, I worship in the "church of what's working now" -- with a twist. When I look for what is "working," I look at the fundamentals, not the charts. My portfolio is always fully loaded with names whose earnings momentum is the best you can find. Within that group, I always prefer lower valuations, and I try to buy names with a price-to-earnings ratio in the bottom half of the range. If the chart looks great, all the better.

So the names I offer today are the best I can find at the moment. They all sport great earnings momentum and reasonable valuations and, for most of them, a great chart.

My caveat is that the fundamentals can change rapidly, so I cannot offer a time frame for ownership. I could be in these names for a month -- or for five years. The holding period depends on how the companies perform and how market expectations react. Predetermining a time period for action is foolish, whether you are the Federal Reserve or a portfolio manager or an individual investor.

I further subdivided this exercise by offering "best ideas" for each S&P 500 sector. (As longtime readers know, I prefer to group by FactSet sector, but there are 16 of them, which is too many for this project.) For each sector, I offer one top large-cap idea and one top mid-cap idea. This will enable you to better diversify both across industries and market-capitalization size.

The table below lists my best ideas for the start of 2014.

In energy, for oilfield services I like "the other HP," Helmrich & Payne (HP). For refining, I like Marathon Petroleum (MPC). H&P is a leading land-contract driller that commands excellent technology to run its rigs, and the company is building on its top market share in land-drilling. As a refiner, Marathon should benefit from the coming glut of oil in the U.S., driven by fracking and horizontal-drilling productivity.

In materials, I like Packaging Corp. of America (PKG) and DuPont (DD). Packaging Corp. stands to benefit from cost savings realized after its acquisition of Boise. DuPont, for its part, is transforming itself from an old-school chemicals giant into a cutting-edge, science-driven company with a focus on enzymes and agricultural innovation that can be utilized in foods, biofuels and biochemicals.

In industrials, I think Boeing (BA) and Xylem (XYL) can soar. Boeing is in the sweet spot of the cycle, enjoying accelerating order rates and improving profitability. Xylem is a leading water-infrastructure name that investors are just starting to discover.

In consumer discretionary, I am bidding on Priceline (PCLN) and Nu Skin (NUS). Priceline is demonstrating the massive leverage that becomes available when the Internet disintermediates an industry, in this case travel agents. Nu Skin is selling beauty products to an aging population in the U.S. and to newly middle-class populations in emerging markets, especially in China.

In consumer staples, I like Mead Johnson Nutrition (MJN) and Energizer (ENR). Mead is selling baby formula into China and other emerging markets -- enough said, if you've been following the baby-formula issues in China. Energizer, meanwhile, is more than a battery company. It also sells sun protection and shaving products.

In healthcare, I am diagnosing success for Forest Labs (FRX) and Gilead Sciences (GILD). Forest is extending a strong franchise in its Namenda Alzheimer's franchise in order to avoid a patent cliff this year, and at the same time the company is acquiring its way into anti-psychosis treatments. Gilead is building momentum on its Sovaldi protease inhibitor, which blew away estimates in the early phase of release at the end of 2013.

In financials, I am investing in Och-Ziff (OZM) and insuring my position with Prudential (PRU). Och-Ziff is seeing very strong inflows resulting from strong performance, which will boost assets under management, revenue and earnings. Prudential will benefit from rising interest rates on U.S. Treasury bonds as it yields more on its investment portfolio.

Finally, in information technology I give a tip of the hat to RedHat (RHT) and Facebook (FB). RedHat is the open-source server software leader, achieving rapid revenue and earnings growth and using a very visible subscription model. We all know Facebook, and while I am neutral on its multiyear outlook due to the saturation factor, I think the company is in the early stages of fully exploiting the current user base.

While I have owned several of these names for some time, many positions are fresh. I just initiated positions in H&P, Marthon, Xylem, NuSkin, Gilead, Och-Ziff and Red Hat.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Dvorchak was long HP, MPC, XYL, PCLN, NUS, MJN, GILD, OZM, PRU, RHT and FB.

TAGS: Investing | U.S. Equity

More from Investing

I Got the 'SOS', So Here's My Take on the Stock's Saga

Timothy Collins
Feb 28, 2021 6:35 PM EST

Let's try to sort out the details of the complicated story of SOS Ltd. -- and why the short reports might be ... selling you short.

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Bob Lang
Feb 28, 2021 10:30 AM EST

These names are displaying both quantitative and technical deterioration.

Jim Cramer: What History Tells Us About Bond-Rate Scares Like This

Jim Cramer
Feb 27, 2021 2:01 PM EST

We could have some real pain ahead for some stocks. Five different kinds.

What's Next for Bonds, TLT and Interest Rates?

Bruce Kamich
Feb 27, 2021 12:30 PM EST

Thoughts and observations on Treasuries and the direction of interest rates.

Navigating a Market Correction

James "Rev Shark" DePorre
Feb 27, 2021 10:00 AM EST

The most critical factor in long-term market success is the ability to effectively navigate market corrections.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:51 AM EST REAL MONEY

    Watch Bob Lang and Doug Kass Discuss Short-Selling!

    Bob Lang and Doug Kass with an engaging and educat...
  • 11:32 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Navigating a Market Correction
  • 11:29 AM EST GARY BERMAN

    Where Does the Nasdaq Go From Here?

    Where does the Nasdaq Composite (CCMP) index go fr...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login